Tumoral response factors after radiofrequency ablation of hepatocellular carcinoma in cirrhotic liver;Factores de respuesta tumoral tras ablación mediante radiofrecuencia del carcinoma hepatocelular sobre cirrosis

Revista Espanola de Enfermedades Digestivas

Volumn 97, Issue 10, 2005, Pages 688-698

  Calleja Kempin, J ^a,b   Colon Rodriguez A ^a   Muro De La Fuente, A ^a   Clemente Ricote, G ^a   Prieto Martin M ^a   Santos Castro, L ^a   Matilla Pena A ^a   Banares Canizares R ^a   Martin Baena D ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Hepatic cirrhosis; Hepatocarcinoma; Radiofrequence; Tumoral ablation

Indexed keywords

AGED; ARTICLE; CANCER SURVIVAL; DEMOGRAPHY; FEMALE; HUMAN; LAPAROSCOPY; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; RADIOFREQUENCY;

EID: 33748307474     PISSN: 11300108     EISSN: 11300108     Source Type: Journal    
DOI: 10.4321/S1130-01082005001000002     Document Type: Article

References (41)

1. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso MC, Sala M, et al. Natural history of untreated nonsurgical hepato-cellular carcinoma: rationale for the desing and evaluation of therapeutic trials. Hepatology 1999; 29: 62-7.
2. Bismuth H, Chiche L, Adam R, Castaign D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145-51.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrosis. New Engl J Med 1996; 334: 693-9.
4. Fuster J, García-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglad T, et al. Hepatocellular carcinoma and cirrhosis: results of surgical treatment in a European Series. Ann Surg 1996; 223: 297-302.
5. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000; 190: 580-7.
6. Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L. Percutaneous interstititial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1966; 167: 759-68.
7. Solbiati L, Goldberg SN, Ierace T, Livraghi T, Meloni F, Dellanoce M. Hepatic metastasis: percutaneous radio-frequency ablation with cool-tip electrodes. Radiology 1997; 205: 367-73.
8. Shi-Ming L, Chun-Jung L, Chen-Chun L, Chao-Wei H, Yi-Cheng C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < 4 cm. Gastroenterology 2004; 127: 1714-23.
9. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma. The BCLC staging classification. Semn Liver Dis 1999; 19: 329-38.
10. Donckier V, Van Laethem JL, Van Gansbeke D, Ickx B, Lingier P, Closset J, et al. New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients. J Surg Oncol 2003; 84: 36-44.
11. Biogourdan JM, Jaek D, Meyer N, Meyer C, Oussoultzogloun E, Bach P, et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9: 513-20.
12. Bruix J, Castels A, Bosch J, Feu J, Fuster J, García-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-23.
13. McGahan, Dodd III GD. Radiofrequency ablation of the liver: current status. AJR 2001; 176: 3-16.
14. Vivarelli M, Guglielmi A, Ruzzanente A, Cucchetti A, Bellusci R, Cordiano C, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 204: 102-7.
15. Llovet JM, Bruix J. Systematic review of randomised trials for unresectable hepatocellular carcinoma:chemoembolization improves survival. Hepatology 2003; 37: 429-42.
16. Giorgio A, Tarantino L, de Stefano G, Scala V, Liorre G, Scarano F, et al. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. AJR 2003; 181: 479-84.
17. Curley SA, Izzo F, Ellis LM,Vauthey JN, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232: 381-91.
18. Izumi N, Ashaina Y, Noguchi O, Uchiara M, Kanazawa N, Itakura J, et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001; 91: 949-56.
19. Bonny C, Abergel A, Gayard P, Chouzet S, Ughetto S, Slim K, et al. Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis. Gastroenterol Clin Biol 2002; 26: 735-41.
20. Horiike N, Iuchi H, Ninomiya T, Kawai K, Kumagi T, Michitaka K, et al. Influencing factors for recurrence of hepatocellular carcinoma treated with radiofrequency ablation. Oncol Rep 2002; 1059-62.
21. Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 2003; 50: 480-4.
22. Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single application of percutaneous radiofrequency ablation. Cancer 2003; 97: 1253-62.
23. Giovannini M, Moutardier V, Danisi C, Bories E, Pesenti C, Delpero JR. Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: results and outcomes in 56 patients. Gastrointest surg 2003; 7: 791-6.
24. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumoral ablation methods: Etanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127 (5 Supl. 1): S159-66.
25. de Baere T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR 2003; 181: 695-700.
26. Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239; 4: 450-8.
27. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, et al. Complications of radiofrequency coagulation of liver tumours. British J Surg 2002; 89: 1206-22.
28. Giorgio A, Tarantino L, de Stefano G, Coppola C, Ferraioli G. Complications after percutaneous saline-enhaced radiofrequency ablation of liver tumours: 3- year experience with 336 patients in a single center. AJR 2005; 184: 207-11.
29. Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST, et al. Learning curve for radiofrequency ablation of liver tumors. Prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004; 239: 441-9.
30. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN, et al. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-51.
31. Patti JW, Neeman Z, Wood BJ. Radiofrequency ablation treatment in proximity to the gallbladder without subsequent acute cholecistitis. Cardiovasc Intervent Radiol 2003; 26: 413-5.
32. Meloni MF, Goldberg SN, Moser V, Piazza G, Livraghi T. Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound 2000; 15 (1-2): 73-6.
33. de Sio I, Castellano L, De Girolamo V, di Santolo SS, Marone A, Del Vecchio, et al. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 609-10.
34. Goldberg SN, Solbiati L. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 609.
35. Livraghi T. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 608-9.
36. Bolondi L, Gaiani S, Celli N, Piscaglia F. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 608.
37. Fontana RJ, Hamidullah H, Nghiem H, Greeson JK. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transplant 2002; 1165-74.
38. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation. A prospective study. Ann Surg 2004; 240: 900-9.
39. Galandi D, Antes G. Radiofrequency thermal ablation versus other interventions. Cochrane Database Syst. Rev 2002; 3: CD003046.
40. Hsieh CB, Chang HM, Chen TW, Chen CJ, Chan DC, Yu JC, et al. Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10: 505-8.
41. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS, et al. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999; 210: 655-61.